A Strategy for Reproducible Protein Quantitation in Gene Therapies Using Ion Mobility Spectrometry
In this GEN webinar, our expert panelists Mark Fielden, PhD, and Jason Apter will discuss strategies to overcome challenges in protein quantitation using Ion Mobility Spectrometry, from early R&D through preclinical and clinical trials for gene therapies.
Accelerating Cell and Gene Therapy Development Using Gene Editing Functional Genomics Approaches
In this GEN webinar, our expert panelists discussed recent insights into the relationship between human genetic variation and disease from functional genomic studies. They shared their preferred strategies for improving payload development and delivery in functional genomics studies using gene editing.
Integrated Strategies to Accelerate Pre-Clinical Development of Antibody-Drug Conjugates
In this GEN webinar, experts from WuXi AppTec shared essential strategies and methodologies for accelerating pre-clinical assessments of ADCs.
Is Biopharma Ready for AI? Exploring Tech Strategies Across Large and Small Biopharma
In this GEN webinar, experts from AbbVie and Benchling will share insights into the current tech landscape, AI readiness, and the strategies for digital transformation shaping large and small biopharma.
Imaging Large Multiprotein Complexes Using Native Nano-DESI Mass Spectrometry
In this GEN webinar, Dr. Helen Cooper, a leading analytic alchemist from the University of Birmingham, U.K., will discuss improvements in mass spectrometry imaging technology that enable the characterization of the precise protein forms present in multiprotein complexes.
Navigating Quality Control and Release Testing in Cell and Gene Therapy Development
In this GEN webinar, our speakers will present important considerations for quality control testing for biosafety and product characterization in GMP release and stability studies of novel cell and gene therapies.
Using Patient-Derived Organoids to Develop Novel Therapies for Complex and Inherited Diseases
In this GEN webinar, experts from Xilis and University of Washington and Plurexa will share results from recent research using patient-derived organoids to study multiple myeloma and polycystic kidney disease.
Mastering the Path: Developing Processes for Successful Clinical-Grade mRNA Manufacturing
In this GEN webinar, we will aim to unlock the secrets behind the iterative process development that ensures the highest standards of mRNA manufacturing.
Using Oxford Nanopore’s Multi-Omic Sequencing to Optimize Plasmids and Vectors for Cell and Gene Therapies
In this GEN webinar, Andrea O'Hara, PhD, a multiomics expert at GENEWIZ from Azenta Life Sciences, will discuss how to use nanopore sequencing technology to enhance the precision and efficiency of cell and gene therapy programs.
Improving Gene Therapy Design and Manufacturability Using Synthetic Biology and AI
In this GEN webinar, Mark Stockdale will discuss how the application of synthetic biology and artificial intelligence can be used to improve the safety, potency and manufacturability of gene therapies, and introduce AAV Edge, a comprehensive platform for end-to-end gene therapy optimization—from payload design to production cell lines and model-guided processes.
Improved Methods for Characterization of AAV-Based Gene Therapies
On this GEN webinar, experts from Regeneron Pharmaceuticals, Song Nie, PhD, and Tim Tiambeng, PhD, will discuss two novel methods for characterizing AAV-based gene therapy products.